Laura E. Niklason - 10 Oct 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
10 Oct 2023
Net transactions value
+$136,160
Form type
4
Filing time
10 Oct 2023, 16:08:08 UTC
Previous filing
15 Sep 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Options Exercise $136,160 +114,420 +9% $1.19 1,384,660 10 Oct 2023 Direct
holding HUMA Common Stock 6,191,140 10 Oct 2023 By Ayabudge LLC
holding HUMA Common Stock 510,161 10 Oct 2023 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Options Exercise $0 -114,420 -70% $0.000000 48,176 10 Oct 2023 Common Stock 114,420 $1.19 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.